Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 2930434, 12 pages
http://dx.doi.org/10.1155/2016/2930434
Review Article

Oxidative Stress Markers in Sputum

1Department of Pathophysiology, National Koranyi Institute of TB and Pulmonology, Piheno Utca 1, Budapest 1121, Hungary
2Department of Pulmonology, National Koranyi Institute of TB and Pulmonology, Piheno Utca 1, Budapest 1121, Hungary

Received 17 July 2015; Revised 15 October 2015; Accepted 18 October 2015

Academic Editor: Daniela Giustarini

Copyright © 2016 Balazs Antus. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Dozor, “The role of oxidative stress in the pathogenesis and treatment of asthma,” Annals of the New York Academy of Sciences, vol. 1203, pp. 133–137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Nadeem, N. Siddiqui, N. O. Alharbi, and M. M. Alharbi, “Airway and systemic oxidant-antioxidant dysregulation in asthma: a possible scenario of oxidants spill over from lung into blood,” Pulmonary Pharmacology and Therapeutics, vol. 29, no. 1, pp. 31–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Kirkham and P. J. Barnes, “Oxidative stress in COPD,” Chest, vol. 144, no. 1, pp. 266–273, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Antus and Z. Kardos, “Oxidative stress in COPD: molecular background and clinical monitoring,” Current Medicinal Chemistry, vol. 22, no. 5, pp. 627–650, 2015. View at Publisher · View at Google Scholar
  5. A. G. Ziady and J. Hansen, “Redox balance in cystic fibrosis,” International Journal of Biochemistry and Cell Biology, vol. 52, pp. 113–123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Galli, A. Battistoni, R. Gambari et al., “Oxidative stress and antioxidant therapy in cystic fibrosis,” Biochimica et Biophysica Acta, vol. 1822, no. 5, pp. 690–713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Holguin, “Oxidative stress in airway diseases,” Annals of the American Thoracic Society, vol. 10, supplement, pp. S150–S157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Louhelainen, M. Myllärniemi, I. Rahman, and V. L. Kinnula, “Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 3, no. 4, pp. 585–603, 2008. View at Google Scholar · View at Scopus
  9. A. Koutsokera, K. Kostikas, L. P. Nicod, and J.-W. Fitting, “Pulmonary biomarkers in COPD exacerbations: a systematic review,” Respiratory Research, vol. 14, article 111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. H. Shoki, N. Mayer-Hamblett, P. G. Wilcox, D. D. Sin, and B. S. Quon, “Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations,” Chest, vol. 144, no. 5, pp. 1659–1670, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Agusti and D. D. Sin, “Biomarkers in COPD,” Clinics in Chest Medicine, vol. 35, no. 1, pp. 131–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. P. J. Barnes, B. Chowdhury, S. A. Kharitonov et al., “Pulmonary biomarkers in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 1, pp. 6–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Malerba and P. Montuschi, “Non-invasive biomarkers of lung inflammation in smoking subjects,” Current Medicinal Chemistry, vol. 19, no. 2, pp. 187–196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Hillas, S. Loukides, K. Kostikas, and P. Bakakos, “Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?” Current Medicinal Chemistry, vol. 16, no. 22, pp. 2824–2838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. L. Borrill, R. C. Starkey, and S. D. Singh, “Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 1, pp. 71–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Franklin, A. Moeller, G. L. Hall, F. Horak Jr., H. Patterson, and S. M. Stick, “Variability of nitric oxide metabolites in exhaled breath condensate,” Respiratory Medicine, vol. 100, no. 1, pp. 123–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Horváth, J. Hunt, P. J. Barnes et al., “Exhaled breath condensate: methodological recommendations and unresolved questions,” European Respiratory Journal, vol. 26, no. 3, pp. 523–548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. B. Schleiss, O. Holz, M. Behnke, K. Richter, H. Magnussen, and R. A. Jörres, “The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate,” European Respiratory Journal, vol. 16, no. 6, pp. 1115–1118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Gajdocsi, A. Bikov, B. Antus, I. Horvath, P. J. Barnes, and S. A. Kharitonov, “Assessment of reproducibility of exhaled hydrogen peroxide concentration and the effect of breathing pattern in healthy subjects,” Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 24, no. 6, pp. 271–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Mazur, H. Stark, A. Sovijärvi, M. Myllärniemi, and V. L. Kinnula, “Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers,” Respiration, vol. 78, no. 2, pp. 209–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Djukanović, P. J. Sterk, J. V. Fahy, and F. E. Hargreave, “Standardised methodology of sputum induction and processing,” European Respiratory Journal Supplement, vol. 37, pp. 1s–2s, 2002. View at Google Scholar · View at Scopus
  22. P. Lacy, J. L. Lee, and D. Vethanayagam, “Sputum analysis in diagnosis and management of obstructive airway diseases,” Therapeutics and Clinical Risk Management, vol. 1, no. 3, pp. 169–179, 2005. View at Google Scholar
  23. I. Rahman and I. M. Adcock, “Oxidative stress and redox regulation of lung inflammation in COPD,” European Respiratory Journal, vol. 28, no. 1, pp. 219–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. I. A. Blair, “DNA adducts with lipid peroxidation products,” Journal of Biological Chemistry, vol. 283, no. 23, pp. 15545–15549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Del Rio, A. J. Stewart, and N. Pellegrini, “A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 15, no. 4, pp. 316–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Giera, H. Lingeman, and W. M. A. Niessen, “Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): a brief overview,” Chromatographia, vol. 75, no. 9-10, pp. 433–440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Karatas, M. Karatepe, and A. Baysar, “Determination of free malondialdehyde in human serum by high-performance liquid chroma tography,” Analytical Biochemistry, vol. 311, no. 1, pp. 76–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. D. W. Wilson, H. N. Metz, L. M. Graver, and P. S. Rao, “Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples,” Clinical Chemistry, vol. 43, no. 10, pp. 1982–1984, 1997. View at Google Scholar · View at Scopus
  29. K. Syslová, P. Kačer, M. Kuzma et al., “Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 877, no. 24, pp. 2477–2486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. J. Forman, O. Augusto, R. Brigelius-Flohe et al., “Even free radicals should follow some rules: a guide to free radical research terminology and methodology,” Free Radical Biology and Medicine, vol. 78, pp. 233–235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Agarwal and S. D. Chase, “Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 775, no. 1, pp. 121–126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Lärstad, G. Ljungkvist, A.-C. Olin, and K. Torén, “Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 766, no. 1, pp. 107–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Corradi, I. Rubinstein, R. Andreoli et al., “Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 10, pp. 1380–1386, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Corradi, P. Pignatti, P. Manini et al., “Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation,” European Respiratory Journal, vol. 24, no. 6, pp. 1011–1017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Antus, G. Harnasi, O. Drozdovszky, and I. Barta, “Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde,” Respirology, vol. 19, no. 1, pp. 74–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Antus, O. Drozdovszky, I. Barta, and K. Kelemen, “Comparison of airway and systemic malondialdehyde levels for assessment of oxidative stress in cystic fibrosis,” Lung, vol. 193, no. 4, pp. 597–604, 2015. View at Publisher · View at Google Scholar
  37. H. Esterbauer, R. J. Schaur, and H. Zollner, “Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes,” Free Radical Biology and Medicine, vol. 11, no. 1, pp. 81–128, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. L. G. Wood, P. G. Gibson, and M. L. Garg, “Biomarkers of lipid peroxidation, airway inflammation and asthma,” European Respiratory Journal, vol. 21, no. 1, pp. 177–186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Banerjee, Kyung Ho Kang, J. D. Morrow, L. J. Roberts, and J. H. Newman, “Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 263, no. 3, pp. H660–H663, 1992. View at Google Scholar · View at Scopus
  40. C. A. Vacchiano and G. E. Tempel, “Role of nonenzymatically generated prostanoid, 8-iso-PGF(2α), in pulmonary oxygen toxicity,” Journal of Applied Physiology, vol. 77, no. 6, pp. 2912–2917, 1994. View at Google Scholar · View at Scopus
  41. L. G. Wood, M. L. Garg, J. L. Simpson et al., “Induced sputum 8-isoprostane concentrations in inflammatory airway diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 5, pp. 426–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. V. L. Kinnula, H. Ilumets, M. Myllärniemi, A. Sovijärvi, and P. Rytilä, “8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD,” European Respiratory Journal, vol. 29, no. 1, pp. 51–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Brindicci, K. Ito, O. Torre, P. J. Barnes, and S. A. Kharitonov, “Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients,” Chest, vol. 135, no. 2, pp. 353–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Louhelainen, P. Rytilä, Y. Obase et al., “The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma,” Journal of Asthma, vol. 45, no. 2, pp. 149–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Aggarwal, Y. P. Moodley, P. J. Thompson, and N. L. Misso, “Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation,” Clinical and Experimental Allergy, vol. 40, no. 1, pp. 85–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Drozdovszky, I. Barta, and B. Antus, “Sputum eicosanoid profiling in exacerbations of chronic obstructive pulmonary disease,” Respiration, vol. 87, no. 5, pp. 408–415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Mohan, D. Prasad, A. Sharma et al., “Delayed resolution of inflammatory response compared with clinical recovery in patients with acute exacerbations of chronic obstructive pulmonary disease,” Respirology, vol. 17, no. 7, pp. 1080–1085, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. D. W. Reid, N. Misso, S. Aggarwal, P. J. Thompson, and E. H. Walters, “Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis,” Respirology, vol. 12, no. 1, pp. 63–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Louhelainen, P. Rytilä, T. Haahtela, V. L. Kinnula, and R. Djukanović, “Persistence of oxidant and protease burden in the airways after smoking cessation,” BMC Pulmonary Medicine, vol. 9, article 25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Gaber, F. Acevedo, I. Delin et al., “Saliva is one likely source of leukotriene B4 in exhaled breath condensate,” European Respiratory Journal, vol. 28, no. 6, pp. 1229–1235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Sugiura and M. Ichinose, “Nitrative stress in inflammatory lung diseases,” Nitric Oxide—Biology and Chemistry, vol. 25, no. 2, pp. 138–144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. F. L. M. Ricciardolo, A. Di Stefano, F. Sabatini, and G. Folkerts, “Reactive nitrogen species in the respiratory tract,” European Journal of Pharmacology, vol. 533, no. 1–3, pp. 240–252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Zuo, M. S. Koozechian, and L. L. Chen, “Characterization of reactive nitrogen species in allergic asthma,” Annals of Allergy, Asthma and Immunology, vol. 112, no. 1, pp. 18–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. W. Domej, K. Oettl, and W. Renner, “Oxidative stress and free radicals in COPD—implications and relevance for treatment,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 1207–1224, 2014. View at Google Scholar
  55. F. C. Fang, “Antimicrobial reactive oxygen and nitrogen species: concepts and controversies,” Nature Reviews Microbiology, vol. 2, no. 10, pp. 820–832, 2004. View at Publisher · View at Google Scholar
  56. R. Spooner and Ö. Yilmaz, “The role of reactive-oxygen-species in microbial persistence and inflammation,” International Journal of Molecular Sciences, vol. 12, no. 1, pp. 334–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Nagababu and J. M. Rifkind, “Determination of s-nitrosothiols in biological fluids by chemiluminescence,” Methods in Molecular Biology, vol. 704, pp. 27–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. M. W. Foster, T. J. McMahon, and J. S. Stamler, “S-nitrosylation in health and disease,” Trends in Molecular Medicine, vol. 9, no. 4, pp. 160–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. K. M. Beeh, J. Beier, N. Koppenhoefer, and R. Buhl, “Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD,” Chest, vol. 126, no. 4, pp. 1116–1122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. B.-J. Lee, Y.-J. Jeung, J.-Y. Lee, and D.-C. Choi, “Increased S-nitrosothiol levels in nonasthmatic eosinophilic bronchitis compared with cough variant asthma,” International Archives of Allergy and Immunology, vol. 156, no. 1, pp. 99–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. A. van der Vliet, J. P. Eiserich, M. K. Shigenaga, and C. E. Cross, “Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease?” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. S. A. Kharitonov and P. J. Barnes, “Exhaled markers of pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 7, pp. 1693–1722, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Saleh, P. Ernst, S. Lim, P. J. Barnes, and A. Giaid, “Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid,” The FASEB Journal, vol. 12, no. 11, pp. 929–937, 1998. View at Google Scholar · View at Scopus
  64. D. Tsikas, A. Mitschke, and F.-M. Gutzki, “Measurement of 3-nitro-tyrosine in human plasma and urine by gas chromatography-tandem mass spectrometry,” Methods in Molecular Biology, vol. 828, pp. 255–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Sugiura, M. Ichinose, M. Tomaki et al., “Quantitative assessment of protein-bound tyrosine nitration in airway secretions from patients with inflammatory airway disease,” Free Radical Research, vol. 38, no. 1, pp. 49–57, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Ichinose, H. Sugiura, S. Yamagata, A. Koarai, and K. Shirato, “Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 2, part 1, pp. 701–706, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Rytilä, T. Rehn, H. Ilumets et al., “Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD,” Respiratory Research, vol. 7, article 69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N. M. Siafakas, “Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD,” Chest, vol. 127, no. 6, pp. 1911–1918, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Sugiura, Y. Komaki, A. Koarai, and M. Ichinose, “Nitrative stress in refractory asthma,” Journal of Allergy and Clinical Immunology, vol. 121, no. 2, pp. 355–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Tsoumakidou, E. Papadopouli, N. Tzanakis, and N. M. Siafakas, “Airway inflammation and cellular stress in noneosinophilic atopic asthma,” Chest, vol. 129, no. 5, pp. 1194–1202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. K. L. Jones, A. H. Hegab, B. C. Hillman et al., “Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum,” Pediatric Pulmonology, vol. 30, no. 2, pp. 79–85, 2000. View at Publisher · View at Google Scholar
  72. A. Van Der Vliet, M. N. Nguyen, M. K. Shigenaga, J. P. Eiserich, G. P. Marelich, and C. E. Cross, “Myeloperoxidase and protein oxidation in cystic fibrosis,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 279, no. 3, pp. L537–L546, 2000. View at Google Scholar · View at Scopus
  73. M. Profita, G. D. Albano, A. M. Montalbano et al., “Acetylcholine leads to signal transducer and activator of transcription 1 (STAT-1) mediated oxidative/nitrosative stress in human bronchial epithelial cell line,” Biochimica et Biophysica Acta, vol. 1832, no. 12, pp. 1949–1958, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Hirano, T. Yamagata, M. Gohda et al., “Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline,” Thorax, vol. 61, no. 9, pp. 761–766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Sugiura, M. Ichinose, S. Yamagata, A. Koarai, K. Shirato, and T. Hattori, “Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD,” Thorax, vol. 58, no. 4, pp. 299–305, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. E. Neofytou, E. G. Tzortzaki, A. Chatziantoniou, and N. M. Siafakas, “DNA damage due to oxidative stress in chronic obstructive pulmonary disease (COPD),” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 16853–16864, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. G. G. Brusselle, G. F. Joos, and K. R. Bracke, “New insights into the immunology of chronic obstructive pulmonary disease,” The Lancet, vol. 378, no. 9795, pp. 1015–1026, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. G. Deslee, J. C. Woods, C. Moore et al., “Oxidative damage to nucleic acids in severe emphysema,” Chest, vol. 135, no. 4, pp. 965–974, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. G. Caramori, I. M. Adcock, P. Casolari et al., “Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer,” Thorax, vol. 66, no. 6, pp. 521–527, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Makris, N. Tzanakis, A. Damianaki et al., “Microsatellite DNA instability and COPD exacerbations,” European Respiratory Journal, vol. 32, no. 3, pp. 612–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. E. G. Tzortzaki, K. Dimakou, E. Neofytou et al., “Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases,” Chest, vol. 141, no. 5, pp. 1243–1250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Proklou, N. Soulitzis, E. Neofytou et al., “Granule cytotoxic activity and oxidative DNA damage in smoking and nonsmoking patients with asthma,” Chest, vol. 144, no. 4, pp. 1230–1237, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Beier, K.-M. Beeh, O. Kornmann, and R. Buhl, “Induced sputum methodology: validity and reproducibility of total glutathione measurement in supernatant of healthy and asthmatic individuals,” Journal of Laboratory and Clinical Medicine, vol. 144, no. 1, pp. 38–44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. N. Dauletbaev, K. Viel, R. Buhl, T. O. F. Wagner, and J. Bargon, “Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis,” Journal of Cystic Fibrosis, vol. 3, no. 2, pp. 119–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Worlitzsch, G. Herberth, M. Ulrich, and G. Döring, “Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis,” European Respiratory Journal, vol. 11, no. 2, pp. 377–383, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Dauletbaev, J. Rickmann, K. Viel et al., “Antioxidant properties of cystic fibrosis sputum,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 288, no. 5, pp. L903–L909, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Zeng, Y. Li, Y. Jiang, G. Lu, X. Huang, and K. Guan, “Local and systemic oxidative stress and glucocorticoid receptor levels in chronic obstructive pulmonary disease patients,” Canadian Respiratory Journal, vol. 20, no. 1, pp. 35–41, 2013. View at Google Scholar · View at Scopus
  88. I. Barta, O. Drozdovszky, and B. Antus, “Monitoring oxidative stress in the lungs: changes in superoxide dismutase (SOD) activity during the course of acute exacerbation of COPD,” European Respiratory Journal, vol. 42, supplement 57, p. S149, 2013. View at Google Scholar
  89. I. Sadowska-Bartosz, S. Galiniak, G. Bartosz, and M. Rachel, “Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 389629, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Maury, F. Gouzi, P. De Rigal et al., “Heterogeneity of systemic oxidative stress profiles in COPD: a potential role of gender,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 201843, 11 pages, 2015. View at Publisher · View at Google Scholar
  91. F. Deveci, N. Ilhan, T. Turgut, N. Akpolat, G. Kirkil, and M. H. Muz, “Glutathione and nitrite in induced sputum from patients with stable and acute asthma compared with controls,” Annals of Allergy, Asthma and Immunology, vol. 93, no. 1, pp. 91–97, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. L. G. Wood, M. L. Garg, R. J. Blake, J. L. Simpson, and P. G. Gibson, “Oxidized vitamin E and glutathione as markers of clinical status in asthma,” Clinical Nutrition, vol. 27, no. 4, pp. 579–586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. N. Dauletbaev, J. Rickmann, K. Viel, R. Buhl, T.-O.-F. Wagner, and J. Bargon, “Glutathione in induced sputum of healthy individuals and patients with asthma,” Thorax, vol. 56, no. 1, pp. 13–18, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Kuipers, R. Louis, M. Manise et al., “Increased glutaredoxin-1 and decreased protein S-glutathionylation in sputum of asthmatics,” European Respiratory Journal, vol. 41, no. 2, pp. 469–472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. N. L. Reynaert, “Glutathione biochemistry in asthma,” Biochimica et Biophysica Acta—General Subjects, vol. 1810, no. 11, pp. 1045–1051, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. M. J. Peltoniemi, P. H. Rytilä, T. H. Harju et al., “Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease,” Respiratory Research, vol. 7, article 133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. P. Gao, P. G. Gibson, J. Zhang et al., “The safety of sputum induction in adults with acute exacerbation of COPD,” The Clinical Respiratory Journal, vol. 7, no. 1, pp. 101–109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. E. Bathoorn, J. Liesker, D. Postma, G. Koëter, A. J. M. Van Oosterhout, and H. A. M. Kerstjens, “Safety of sputum induction during exacerbations of COPD,” Chest, vol. 131, no. 2, pp. 432–438, 2007. View at Publisher · View at Google Scholar · View at Scopus